ArticleInternational journal of clinical oncology2026
Real-world evaluation of primary prophylactic use of granulocyte colony-stimulating factor in patients with metastatic castration-sensitive prostate cancer treated with triplet therapy.
Masataka Kubo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.